[ARWR] YoY Quarter Result on 30-Sep-2023 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
29-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q4]
Profit Trend
QoQ- -6.54%
YoY- -27.62%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 16,097 31,575 38,283 7,633 43,293 11,255 -
PBT -172,798 -108,990 -82,157 -63,372 -48,430 11,878 -10,759 58.77%
Tax 546 2,025 3,785 2 2 174 2 154.48%
NP -170,536 -109,679 -85,942 -63,374 -48,433 11,705 -10,761 58.42%
Tax Rate - - - - - -1.46% - -
Total Cost 170,536 125,776 117,517 101,657 56,066 31,588 22,016 40.61%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 -681.36 -272.18 -165.54 -634.53 27.04 -95.61 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 0.00 -1.02 -0.81 -0.61 -0.47 0.12 -0.12 -
EPS Diluted 0.00 -1.02 -0.81 -0.61 -0.47 0.12 -0.11 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.